James M. Hinson

Corporate Officer/Principal en Unicorn Pharma Consulting, Inc. .

73 años

Consumer Services

Health Technology

Perfil

James M.
Hinson is currently the owner of Unicorn Pharma Consulting, Inc. He was formerly the Chief Medical Officer at Aldagen, Inc. He holds a doctorate degree from Vanderbilt University and an undergraduate degree from the University of Missouri.

Cargos activos de James M. Hinson

Empresas	Cargo	Inicio
Unicorn Pharma Consulting, Inc.	Corporate Officer/Principal	06/11/2009

Todos los cargos activos de James M. Hinson

Antiguos cargos conocidos de James M. Hinson.

Empresas	Cargo	Fin
Aldagen, Inc. Aldagen, Inc. Pharmaceuticals: GenericHealth Technology Aldagen, Inc. develops and produces pharmaceutical products. It focuses on developing product candidates to address cardiovascular disease. The firm develops ALD-301 for the treatment of critical limb ischemia; ALD-201 for the treatment of ischemic heart failure; and ALD-401 for the post-acute treatment of ischemic stroke. The company also supplies ALDHbr cells for use in investigator-sponsored clinical studies. Aldagen was founded by Andrew E. Balber, Michael Sherman Colvin, Clay Smith and Nelson Chao in March 2000 and is headquartered in Durham, NC.	Director Técnico/Científico/I+D	-

Ver el detalle de la experiencia de James M. Hinson.

Formación de James M. Hinson.

University of Missouri	Undergraduate Degree
Vanderbilt University	Doctorate Degree

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas